Fish oil for brain side effects? study pulled before start
NCT ID NCT00621634
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if high-dose DHA (an omega-3 fatty acid) could reduce involuntary movements in people with tardive dyskinesia, a side effect of long-term antipsychotic medication. It planned to enroll 40 adults aged 30-75 with schizophrenia and tardive dyskinesia, giving them DHA or placebo for 12 weeks. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Douglas Mental Health University Institute
Montreal, Quebec, H4H 1R3, Canada
-
Notre-Dame Hospital/CHU Montreal
Montreal, Quebec, H2L 4M1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?